Category Archive: drug costs

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

Medicaid Patients In Puerto Rico Don’t Get Coverage For Drugs To Cure Hepatitis C

The program that provides health care for about half of the U.S. territory’s population cannot afford to cover the drugs.

Podcast: KHN’s ‘What The Health?’ Ask Us Anything!

From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners’ questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner.

5 Ways Nixing The Affordable Care Act Could Upend The Entire Health System

There could be a long legal struggle ahead over the decision by a judge in Texas to invalidate the federal health law. But if his decision stands, it would have long-lasting effects on health care from insurance coverage to Medicare payments to privacy protections.

Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs

Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from “biosimilars.” It’s a very different story in Europe.

For The Asking, A Check Is In The Mail To Help Pay For Costly Drugs

It’s a little-known secret that patients can get thousands of dollars directly from a drugmaker.

No Cash, No Heart. Transplant Centers Require Proof Of Payment.

The case of a Michigan woman told to fundraise $10,000 for a heart transplant sparked viral outrage, but experts say “wallet biopsies” are common.

Podcast: KHN’s ‘What The Health?’ Reading The Tea Leaves In Blue Wave’s Wake

In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”

Democrats Taking Key Leadership Jobs Have Pocketed Millions From Pharma

Top House Republican also received more than $1 million from drugmakers since 2007.

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

Older posts «

Explore the Archive